Parallel imaging in breast MR improves lesion characterization and significantly reduces scan time, allowing for shorter bilateral examinations, according to researchers at Saint Barnabas Medical Center in Livingston, NJ.
Parallel imaging in breast MR improves lesion characterization and significantly reduces scan time, allowing for shorter bilateral examinations, according to researchers at Saint Barnabas Medical Center in Livingston, NJ.
Dr. Paul D. Friedman and colleagues have scanned approximately 1300 patients since January 2002 in the largest ongoing application to date of sensitivity encoded (SENSE) technology. SENSE imaging dropped scanning time to 22 minutes for bilateral scans, improved patient comfort, increased throughput, and reduced costs, the researchers wrote in the February issue of the American Journal of Roentgenology.
Before SENSE imaging became available, unilateral imaging took 30 minutes and required two patient visits, two contrast injections, and subtraction images. Temporal resolution was greater than one minute.
Breast MRI is generally considered an expensive technique with a relatively low specificity. With continued improvements, however, it will become even more beneficial and, possibly, will become an effective screening tool, the investigators concluded.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.